<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://lipidbank.jp/mediawiki/index.php?action=history&amp;feed=atom&amp;title=LBF20307PG06</id>
	<title>LBF20307PG06 - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://lipidbank.jp/mediawiki/index.php?action=history&amp;feed=atom&amp;title=LBF20307PG06"/>
	<link rel="alternate" type="text/html" href="https://lipidbank.jp/mediawiki/index.php?title=LBF20307PG06&amp;action=history"/>
	<updated>2026-04-30T18:11:21Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.0</generator>
	<entry>
		<id>https://lipidbank.jp/mediawiki/index.php?title=LBF20307PG06&amp;diff=53934&amp;oldid=prev</id>
		<title>Editor at 09:02, 21 October 2010</title>
		<link rel="alternate" type="text/html" href="https://lipidbank.jp/mediawiki/index.php?title=LBF20307PG06&amp;diff=53934&amp;oldid=prev"/>
		<updated>2010-10-21T09:02:16Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 18:02, 21 October 2010&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l6&quot;&gt;Line 6:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 6:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|LipidBank=XPR1768&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|LipidBank=XPR1768&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|LipidMaps=LMFA03010086&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|LipidMaps=LMFA03010086&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|SysName=9-Oxo-15R-hydroxy-16,16-dimethyl-prosta-  (5&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-cis&lt;/del&gt;,10,13&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-trans&lt;/del&gt;)  -trien-1-oic acid&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|SysName=9-Oxo-15R-hydroxy-16,16-dimethyl-prosta-  (&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;cis-&lt;/ins&gt;5,10,&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;trans-&lt;/ins&gt;13)  -trien-1-oic acid&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|Common Name=&amp;amp;&amp;amp;16,16-dimethyl Prostaglandin A_2&amp;amp;&amp;amp;9-Oxo-15R-hydroxy-16,16-dimethyl-prosta- (5Z,10,13E) -trien-1-oic acid&amp;amp;&amp;amp;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|Common Name=&amp;amp;&amp;amp;16,16-dimethyl Prostaglandin A_2&amp;amp;&amp;amp;9-Oxo-15R-hydroxy-16,16-dimethyl-prosta- (5Z,10,13E) -trien-1-oic acid&amp;amp;&amp;amp;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|Solubility= 16,16-dimethyl Prostaglandin A2 is soluble in organic solvents (i.e. methyl acetate, DMSO, ethanol) at least 50 mg/ml and also in aqueous buffers or isotonic saline at least 2.4 mg/ml. But in basic solutions (pH &amp;gt;7.4) 16,16-dimethyl Prostaglandin A2 will be converted into 16,16-dimethyl Prostaglandin PGB2.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|Solubility= 16,16-dimethyl Prostaglandin A2 is soluble in organic solvents (i.e. methyl acetate, DMSO, ethanol) at least 50 mg/ml and also in aqueous buffers or isotonic saline at least 2.4 mg/ml. But in basic solutions (pH &amp;gt;7.4) 16,16-dimethyl Prostaglandin A2 will be converted into 16,16-dimethyl Prostaglandin PGB2.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Editor</name></author>
	</entry>
	<entry>
		<id>https://lipidbank.jp/mediawiki/index.php?title=LBF20307PG06&amp;diff=53933&amp;oldid=prev</id>
		<title>Editor: New page: {{Lipid/Header}}  {{Hierarchy|{{PAGENAME}}}}  {{Metabolite |LipidBank=XPR1768 |LipidMaps=LMFA03010086 |SysName=9-Oxo-15R-hydroxy-16,16-dimethyl-prosta-  (5-cis,10,13-trans)  -trien-1-oic a...</title>
		<link rel="alternate" type="text/html" href="https://lipidbank.jp/mediawiki/index.php?title=LBF20307PG06&amp;diff=53933&amp;oldid=prev"/>
		<updated>2010-09-16T08:51:30Z</updated>

		<summary type="html">&lt;p&gt;New page: {{Lipid/Header}}  {{Hierarchy|{{PAGENAME}}}}  {{Metabolite |LipidBank=XPR1768 |LipidMaps=LMFA03010086 |SysName=9-Oxo-15R-hydroxy-16,16-dimethyl-prosta-  (5-cis,10,13-trans)  -trien-1-oic a...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{Lipid/Header}}&lt;br /&gt;
&lt;br /&gt;
{{Hierarchy|{{PAGENAME}}}}&lt;br /&gt;
&lt;br /&gt;
{{Metabolite&lt;br /&gt;
|LipidBank=XPR1768&lt;br /&gt;
|LipidMaps=LMFA03010086&lt;br /&gt;
|SysName=9-Oxo-15R-hydroxy-16,16-dimethyl-prosta-  (5-cis,10,13-trans)  -trien-1-oic acid&lt;br /&gt;
|Common Name=&amp;amp;&amp;amp;16,16-dimethyl Prostaglandin A_2&amp;amp;&amp;amp;9-Oxo-15R-hydroxy-16,16-dimethyl-prosta- (5Z,10,13E) -trien-1-oic acid&amp;amp;&amp;amp;&lt;br /&gt;
|Solubility= 16,16-dimethyl Prostaglandin A2 is soluble in organic solvents (i.e. methyl acetate, DMSO, ethanol) at least 50 mg/ml and also in aqueous buffers or isotonic saline at least 2.4 mg/ml. But in basic solutions (pH &amp;gt;7.4) 16,16-dimethyl Prostaglandin A2 will be converted into 16,16-dimethyl Prostaglandin PGB2.&lt;br /&gt;
|UV Spectra= lambda max=215nm  epsilon 216=12200&lt;br /&gt;
|Source=&lt;br /&gt;
|Chemical Synthesis=&lt;br /&gt;
|Metabolism=&lt;br /&gt;
|Biological Activity= 16,16-dimethyl Prostaglandin A2 shows inhibitory effect on the proliferation of Sendai virus in monkey cells.[[Reference:Tanaka_T:Hazato_A:Bannai_K:Okamura_N:Sugiura_S:Manabe_K:Toru_T:Kurozumi_S:Suzuki_M:Kawagishi_T_et_al:,Tetrahedron,1987,43,813|{{RelationTable/GetFirstAuthor|Reference:Tanaka_T:Hazato_A:Bannai_K:Okamura_N:Sugiura_S:Manabe_K:Toru_T:Kurozumi_S:Suzuki_M:Kawagishi_T_et_al:,Tetrahedron,1987,43,813}}]] 16,16-dimethyl Prostaglandin A2 significantly increases mouse survival against nfection with influenza A by an average of 40% and decreases virus titers in the lungs without alteration of the host immune response.[[Reference:Santoro_MG:Favalli_C:Mastino_A:Jaffe_BM:Esteban_M:Garaci_E:,Arch. Virol.,1988,99,89|{{RelationTable/GetFirstAuthor|Reference:Santoro_MG:Favalli_C:Mastino_A:Jaffe_BM:Esteban_M:Garaci_E:,Arch. Virol.,1988,99,89}}]]&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
{{Lipid/Footer}}&lt;/div&gt;</summary>
		<author><name>Editor</name></author>
	</entry>
</feed>